| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 23.48M | 13.07M | 17.91M | 15.36M | 14.27M |
| Gross Profit | 21.64M | 13.07M | 10.64M | 15.21M | 14.14M |
| EBITDA | 11.38M | 9.43M | 0.00 | -5.76M | 1.09M |
| Net Income | 5.80M | -1.31M | -3.98M | -19.82M | 275.41K |
Balance Sheet | |||||
| Total Assets | 129.69B | 154.85M | 125.60M | 86.32M | 122.08M |
| Cash, Cash Equivalents and Short-Term Investments | 14.32B | 5.67M | 3.72M | 6.01M | 8.42M |
| Total Debt | 27.35B | 144.55M | 114.30M | 71.23M | 86.32M |
| Total Liabilities | 117.07B | 148.03M | 117.47M | 74.19M | 89.08M |
| Stockholders Equity | 12.62B | 6.82M | 8.13M | 12.12M | 33.00M |
Cash Flow | |||||
| Free Cash Flow | 2.88B | 3.19M | 1.70M | 5.43M | 5.53M |
| Operating Cash Flow | 2.88B | 3.19M | 1.70M | 5.48M | 5.53M |
| Investing Cash Flow | 35.89B | -30.49M | -47.06M | 7.62M | 1.35M |
| Financing Cash Flow | -31.88B | 30.25M | 43.05M | -16.14M | -7.98M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | $48.50M | 13.06 | 12.22% | 9.28% | -8.80% | -5.99% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
55 Neutral | $99.20M | -25.12 | 2.95% | 21.65% | 22.14% | ― | |
55 Neutral | $45.09M | 7.73 | 3.56% | 19.80% | -63.70% | -325.57% | |
53 Neutral | $28.19M | 5.11 | 108.44% | ― | 22.95% | ― | |
53 Neutral | $67.03M | 14.34 | 4.21% | 23.03% | -31.69% | -72.10% | |
45 Neutral | $71.35M | -1.19 | -7.12% | 7.97% | -28.13% | 62.49% |
On March 12, 2026, Bimini Capital Management reported net income of $3.4 million, or $0.34 per share, for the fourth quarter of 2025 and $5.8 million, or $0.58 per share, for the full year, with book value per share at $1.26 as of December 31, 2025. Results were driven largely by rising advisory revenues tied to strong performance at managed REIT Orchid Island Capital and gains in the company’s MBS and hedging portfolios, despite interest expense and operating costs.
The board also authorized a new share repurchase plan of up to $2.5 million over 24 months and disclosed that a Bimini subsidiary had agreed on January 13, 2026, to acquire 80% of registered investment adviser Tom Johnson Investment Management. The planned TJIM acquisition, to be funded in part by liquidating most of Bimini’s Agency RMBS portfolio, is intended to broaden and diversify its advisory platform while reducing leverage, signalling a strategic shift in the firm’s revenue mix and risk profile for shareholders.
The most recent analyst rating on (BMNM) stock is a Hold with a $4.00 price target. To see the full list of analyst forecasts on Bimini Capital Management stock, see the BMNM Stock Forecast page.
On January 13, 2026, Bimini Capital Management announced that its wholly owned subsidiary Bimini Advisors Holdings agreed to acquire 80% of Tom Johnson Investment Management, LLC (TJIM), a privately held registered investment adviser with approximately $1.6 billion in assets under management across equity and fixed income strategies, in a cash transaction valued at 2.5 times 80% of TJIM’s 2025 revenue, with any amount above $12 million paid in deferred installments. The deal, targeted to close by the end of the first quarter of 2026 subject to customary due diligence, regulatory and client consents, and new employment agreements for TJIM’s leadership, includes options for either party to trigger the eventual purchase of the remaining 20% stake after the third anniversary of closing and is intended to transform Bimini into a pure asset management firm with a more diversified asset base, while preserving TJIM’s existing management team, incentivizing staff retention through potential equity participation, and leveraging Bimini’s public company infrastructure and capital markets access to support future asset growth.
The most recent analyst rating on (BMNM) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Bimini Capital Management stock, see the BMNM Stock Forecast page.